Market Checkup: Sept. 18, 2013

Market Checkup: Sept. 18, 2013

Today's edition of The Motley Fool's health-care show Market Checkup covers a new drug application from pharmaceutical giant AstraZeneca and a biotech company rumored to be for sale.

9 solid dividend stocks
If you're on the lookout for high-yielding stocks outside of the health care sector, The Motley Fool's special free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks. Grab your free copy today by clicking here.

The article Market Checkup: Sept. 18, 2013 originally appeared on

David Williamson owns shares of Pfizer and Amarin. Alison Southwick and Max Macaluso, Ph.D., have no position in any stocks mentioned. The Motley Fool recommends BioMarin Pharmaceutical. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Originally published